A Novel ATM Gene Mutation Affecting Splicing in an Ataxia-Telangiectasia Patient

Ates E. A., TÜRKYILMAZ A., Eltan S. B., BARIŞ S., GÜNEY A. İ.

MOLECULAR SYNDROMOLOGY, cilt.13, sa.1, ss.80-84, 2022 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 13 Sayı: 1
  • Basım Tarihi: 2022
  • Doi Numarası: 10.1159/000518629
  • Dergi Adı: MOLECULAR SYNDROMOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, EMBASE
  • Sayfa Sayıları: ss.80-84
  • Anahtar Kelimeler: ATM, Ataxia-telengiectasia syndrome, Splicing mutation, Novel mutation, cDNA sequencing, IDENTIFICATION
  • Marmara Üniversitesi Adresli: Evet

Özet

Ataxia-telangiectasia (AT) is an autosomal recessive disorder characterized by progressive ataxia, choreoathetosis and immunodeficiency beginning in early childhood. An 8-year-old girl was referred with a diagnosis of AT. She had gait disturbance and dysarthria for 3years. Multiple cutaneous telangiectases were observed on her face, trunk and limbs. Sequence analysis of the ATM gene revealed a homozygous c.7308-15A>G mutation in IVS49. Human Splicing Finder predicted that the mutation could activate an intronic cryptic acceptor site. We designed primers for amplification of related exons (48-50) from cDNA for evaluating splicing pattern. Sequencing of ATM exons 48-50 revealed a 14-nucleotide insertion from intron 49, between exons 49 and 50, resulting in premature termination of translation at codon 2439. To conclude, we report a novel mutation in a classical AT case, which resulted in an alternatively spliced transcript and was predicted to form a truncated protein or null protein due to nonsense-mediated decay.